Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03340038 · ClinicalTrials.gov registry record · NA

Use of a Non-ICU Specialty Ward For Immediate Post-operative Management of Head and Neck Free Flaps

A NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT03340038 is a NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma that has completed, run by University of California, Davis. The registered enrollment target is 112 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03340038, a NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

Patients undergoing free flap reconstructive surgery at University of California, Davis Medical Center (UCDMC) will be assigned randomly into no intervention group (immediate post operative care in an ICU) or intervention group (immediate post operative care in a non-ICU specialty ward). The investigators hypothesize that there is no significant difference in the length of stay (LOS) or complication rate between head and neck free flaps patients managed immediately post-operatively in an ICU versus a non-ICU specialty ward. The primary objective is to compare the postoperative LOS between head and neck free-flap patients managed initially in an ICU versus a non-ICU specialty ward. The secondary objective is to compare differences in the rate of complications between head and neck free flap patients managed initially in an ICU versus a non-ICU specialty ward. Finally, the tertiary objective is to compare differences in resource utilization between head and neck free-flap patients managed initially in an ICU versus a non-ICU specialty ward.

Interventions

  • OTHER Non-ICU Specialty ward

Study Locations (1)

California

  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2016-04-10
Est. Completion 2019-04-16
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03340038

The ClinicalTrials.gov registry entry for NCT03340038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (57% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Non-ICU Specialty ward is the first listed.

NCT03340038 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03340038 about?

NCT03340038 is a clinical study titled "Use of a Non-ICU Specialty Ward For Immediate Post-operative Management of Head and Neck Free Flaps". Patients undergoing free flap reconstructive surgery at University of California, Davis Medical Center (UCDMC) will be assigned randomly into no intervention group (immediate post operative care in an ICU) or intervention group (immediate post operative care in a non-ICU specialty ward). The investi...

What is the current status of trial NCT03340038?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2016-04-10. Estimated completion is 2019-04-16.

What conditions does trial NCT03340038 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Trauma, Head and Neck Carcinoma.

What interventions are being tested in trial NCT03340038?

The interventions under investigation include: Non-ICU Specialty ward (OTHER).

Who is sponsoring clinical trial NCT03340038?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03340038 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.